Sp639
LONG-TERM OUTCOMES AND COMPLICATIONS OF COVID IN IBD PATIENTS
Date
May 7, 2023
Explore related products in the following collection:
Tracks
Related Products
INTRODUCTION
SOCIETY: AGA
PANEL DISCUSSION: IMMUNISATION AND SUSCEPTIBILITY TO INFECTION IN PATIENTS WITH IBD
The Cochrane Gut group supports the production of high quality and methodologically rigorous reviews for a portfolio that includes upper GI, IBD and functional bowel disease topics in adults and children…
PANEL DISCUSSION: REMOTE TELEHEALTH AND PATIENT EDUCATION TO SUPPORT POST COVID IBD CARE
The Cochrane Gut group supports the production of high quality and methodologically rigorous reviews for a portfolio that includes upper GI, IBD and functional bowel disease topics in adults and children…
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…